// App-Quantinova.ai

P465 : Do infliximab trough levels differ between adult and paediatric patients with Crohn’s disease in clinical remission?

Researchers

Presenter

  • A Cavazza

Principal Investigators

  • N Mavroeidi

  • A Steel

  • L Greathead

  • W Kelleher

  • M Wahed

Medical Centers

  • Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom

  • Royal Liverpool University Hospital, Liverpool, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • N/A

Biomarkers

  • C reactive protein

Drug/Treatment

  • Infliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved